Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Afferent Loop Syndrome

Rebecca K. Grotewiel  1 , Renford Cindass  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Book

Afferent Loop Syndrome

Rebecca K. Grotewiel et al.

Excerpt

Afferent loop syndrome (ALS) is an uncommon mechanical complication that can occur after various upper gastrointestinal procedures involving anastomosis of the stomach or esophagus to the jejunum. Classically described with Billroth II gastrojejunostomy, other common procedures such as Roux-en-Y gastrojejunostomy, Roux-en-Y esophagojejunostomy, and the Whipple procedure are also associated with afferent loop syndrome.

Following a Billroth II reconstruction, the afferent loop is comprised of the gastric/duodenal stump, duodenum, and the short segment of jejunum proximal to the gastrojejunostomy. Following Roux-en-Y gastric bypass, the biliopancreatic limb remains connected to the remnant stomach and is anastomosed distally via jejunojejunostomy.

The afferent limb transfers bile, pancreatic, and proximal intestinal secretions distally towards the anastomosis (gastrojejunostomy in Billroth II/Whipple procedures and jejunojejunostomy in Roux-en-Y). The efferent loop receives and transfers the ingested food and liquids. Afferent loop syndrome is defined by a distal obstruction causing distension of the afferent limb secondary to the accumulation of bile, pancreatic fluid, and proximal small bowel secretions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Rebecca Grotewiel declares no relevant financial relationships with ineligible companies.

Disclosure: Renford Cindass declares no relevant financial relationships with ineligible companies.

References

    1. Nageswaran H, Belgaumkar A, Kumar R, Riga A, Menezes N, Worthington T, Karanjia ND. Acute afferent loop syndrome in the early postoperative period following pancreaticoduodenectomy. Ann R Coll Surg Engl. 2015 Jul;97(5):349-53. - PMC - PubMed
    1. Kawamoto Y, Ome Y, Kouda Y, Saga K, Park T, Kawamoto K. Pancreaticoduodenectomy following gastrectomy reconstructed with Billroth II or Roux-en-Y method: Case series and literature review. Int J Surg Case Rep. 2017;35:106-109. - PMC - PubMed
    1. Dias AR, Lopes RI. Biliary stone causing afferent loop syndrome and pancreatitis. World J Gastroenterol. 2006 Oct 14;12(38):6229-31. - PMC - PubMed
    1. Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A. Management of afferent loop obstruction: Reoperation or endoscopic and percutaneous interventions? World J Gastrointest Surg. 2015 Sep 27;7(9):190-5. - PMC - PubMed
    1. Lee KD, Liu TW, Wu CW, Tiu CM, Liu JM, Chung TR, Chang JY, Whang-Peng J, Chen LT. Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin. Ann Oncol. 2002 Jul;13(7):1151-5. - PubMed

Publication types

LinkOut - more resources